News

Fitness

NAD+ and aging muscle: a new mouse study maps a fat-to-muscle signal

By Matthew Spencer

Published · Updated

A man in a gray tank top holding red dumbbells in a gym
Illustrative stock photo.

If you take NMN or NR (example: Tru Niagen) in the hope of keeping muscle as you age, a new mouse study in Cell Metabolism is the most interesting mechanism paper this month. It still does not prove your supplement works.

What it offers is a complete signal chain, from fat tissue to muscle, that explains how raising NAD+ protected mice from several kinds of muscle loss. Here is what was actually shown, and what remains unproven in people.

What the study found

Researchers raised NAD+ levels in the fat tissue of mice. That switched on production of a protein called Serpina3n through the transcription factor STAT1, and the protein was released into circulation.

Serpina3n then protected muscle in three separate mouse models of muscle loss: aging, disuse, and cancer cachexia. Injecting the protein directly improved muscle atrophy, while deleting it from fat tissue worsened muscle function.

Inside muscle, Serpina3n preserved levels of pyruvate carboxylase, an enzyme that refills the cell's energy cycle. The downstream effects involved mTOR signalling and protein synthesis, both central to maintaining muscle.

Why researchers care

Muscle loss with age drives frailty and disability, yet how body-wide metabolic cues protect muscle has been unclear. This paper proposes one complete inter-organ axis: fat tissue senses NAD+ and sends a protective signal to muscle.

It also gives drug developers a named target. The authors have filed a provisional patent on using Serpina3n against muscle atrophy, which is worth knowing when a mechanism sounds this tidy.

What this does not prove for NAD+ supplements

Every layer of this work is in mice and cell cultures. No humans received anything, and the study says nothing about whether NMN or NR pills reproduce the effect in people.

Human trials so far point the other way on outcomes. A 2025 meta-analysis of randomized trials in adults over 60 found that NMN and NR did not significantly improve muscle mass, grip strength, gait speed or chair-stand performance versus placebo.

Supplements like NMN and NR can raise NAD+ availability in people, but turning that into measurably stronger muscles has not been demonstrated. This study does not change that picture.

The bottom line

This is a mechanism win, not a supplement win. If you already use NMN or NR, nothing here adds human evidence for muscle preservation, and the trial data we have found no significant benefit on muscle outcomes in older adults.

The levers with direct human evidence for keeping muscle remain resistance training and adequate protein. If Serpina3n or this fat-to-muscle pathway is ever tested in humans, that would be genuinely new information.

Product links in this article are affiliate links. If you buy through them we may earn a commission at no extra cost to you.

Sources (3)

This is news reporting and not medical advice.